CIS news

• Senhance received extended FDA clearance
• More media focus on Auris
• On Vanderbilt's flexible MIS system
• The da Vinci SP is now officially cleared for radical prostatectomy, pyeloplasty, nephrectomy, and partial nephrectomy
• The Robotic Surgery Revolution is just getting started
• New dual arm, MR compatible robot for DBS from Hong Kong
• Australia poised for a boom in robotic surgery 
• Keyhole may trump robotic surgery for mitral valve repair
• World’s first Da Vinci-Assisted spinal tumor surgery in Philadelphia
• Preceyes performed well in first robot assisted retinal surgery
• Study: No difference in complications, survival rate between robot-assisted and open bladder surgery, published in the Lancet
• Scottish NHS hospital is the first in the UK to use da Vinci in lung-cancer surgery
• Verb Surgical is expanding to a new 234,000 square feet office
•   
• Intuitive Surgical agrees to settle securities litigation for $42.5M
•  Medrobotics announces $25M venture debt investment 
• Transenterix's stock on the rise
• Investing in Surgical Robotic Companies
• RoboSummit 2018: Building a Community of Vascular Robotics Users
• CMR raises $100 m Series B from a Chinese fund to commercialize its Versius system
• CRAS is coming to London this year